Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Development and validation of a blinded hybrid device according to the European Hypertension Society protocol: Nissei DM-3000

Abstract

Both automated and auscultatory blood pressure (BP) devices have their strengths and accuracy limitations. Hybrid devices, such as the Nissei DM-3000, are mercury free and provide both automated and auscultatory measurement modes. The aim of this study was to validate all measurement modes of the Nissei DM-3000 device according to the European Society of Hypertension (ESH) protocol, as well as to develop and validate a ‘blinded’ auscultatory measurement mode. Different measurement modes were developed and evaluated in separate studies. Nine sequential same-arm BP measurements were taken alternating between simultaneous mercury sphygmomanometer readings and the device. The latter seven measurements were analysed according to the requirements of the ESH protocol. All measurement modes of the device passed the ESH protocol. The blinded mode achieved the best results with a mean difference±s.d. of −0.1±2.6 and 0.04±2.4 mm Hg for systolic BP (SBP) and diastolic BP (DBP), respectively. The most accurate auscultatory measurement results were obtained with a deflation rate of 2.5 mm Hg s−1 achieving a mean difference±s.d. of −0.6±4.4 (for SBP) and −1.4±2.8 mm Hg (for DBP). The automated mode achieved a mean difference±s.d. of −0.8±6.0 (SBP) and 0.8±4.8 mm Hg (DBP). The Nissei DM-3000 device is a suitable replacement for the mercury sphygmomanometer.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Pickering T, Hall J, Appel L, Falkner B, Graves J, Hill M et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension 2005; 45: 142–161.

    Article  CAS  Google Scholar 

  2. Waugh J, Gupta M, Rushbrook J, Halligan A, Shennan AH . Hidden errors of aneroid sphygmomanometers. Blood Press Monit 2002; 7: 309–312.

    Article  Google Scholar 

  3. Langford N, Ferner R . Toxicity of mercury. J Hum Hypertens 1999; 10: 651–656.

    Article  Google Scholar 

  4. O'Brien E . Demise of the mercury sphygmomanometer and the dawning of a new era in blood pressure measurement. Blood Press Monit 2003; 8: 19–21.

    Article  Google Scholar 

  5. van Ittersum FJ, Wijering RM, Lambert J, Donker AJ, Stehouwer CD . Determinants of the limits of agreement between the sphygmomanometer and the SpaceLabs 90207 device for blood pressure measurement in health volunteers and insulin-dependent diabetic patients. J Hypertens 1998; 16: 1125–1130.

    Article  CAS  Google Scholar 

  6. Anastas ZM, Jimerson E, Garolis S . Comparison of non-invasive blood pressure measurements in patients with atrial fibrillation. J Cardiovasc Nurs 2008; 23: 519–524.

    Article  Google Scholar 

  7. Shennan AH, de Greeff A . Measuring blood pressure in pregnancy and pre-eclampsia. In: Lyall F, Belfort M (eds). Pre-eclampsia, Etiology and Clinical Practice, Vol. 18 Cambridge University Press: Cambridge, 2007 pp 258–275.

    Google Scholar 

  8. Omboni S, Riva I, Giglio A, Caldara G, Groppelli A, Parati G . Validation of the Omron M5-I, R5-I and HEM-907 automated blood pressure monitors in elderly individuals according to the International Protocol of the European Society of Hypertension. Blood Press Monit 2007; 12: 233–242.

    Article  Google Scholar 

  9. Pickering TG . What will replace the mercury sphygmomanometer? Blood Press Monit 2003; 8: 23–25.

    Article  Google Scholar 

  10. Pickering T . The case for a hybrid sphygmomanometer. Blood Press Monit 2001; 6: 177–179.

    Article  CAS  Google Scholar 

  11. Graves J, Tibor M, Murtagh B, Klein L, Sheps S . The Accuson Greenlight 300, the first non-automated mercury-free blood pressure measurement device to pass the International Protocol for blood pressure measuring devices in adults. Blood Press Monit 2004; 9: 13–17.

    Article  Google Scholar 

  12. Stergiou GS, Giovas PP, Gkinos CP, Tzamouranis DG . Validation of the A&D UM-101 professional hybrid device for office blood pressure measurement according to the International Protocol. Blood Press Monit 2008; 13: 37–42.

    Article  Google Scholar 

  13. Tasker F, de Greeff A, Liu B, Shennan AH . Validation of a non-mercury digital auscultatory device according to the European Hypertension Society protocol: Rossmax Mandaus II. Blood Press Monit 2009; 14: 121–124.

    Article  Google Scholar 

  14. Wilton A, Shabeeh H, Cuckson C, Shennan A . Validation of a non-mercury digital auscultatory device with manual pressure registration (PMS Mandaus). Blood Press Monit 2006; 11: 161–164.

    Article  Google Scholar 

  15. O'Brien E, Pickering T, Asmar R, Myers M, Parati G, Staessen J et al. Working group on blood pressure monitoring of the European Society of Hypertension International Protocol for validation of blood pressure measuring devices in adults. Blood Press Monit 2002; 7: 3–17.

    Article  Google Scholar 

  16. British Hypertension Society Blood Pressure Measurement Tutorial. http://www.abdn.ac.uk/medical/bhs/, 1999.

  17. Association for the Advancement of Medical Instrumentation. American National Standard for Electronic or Automated Sphygmomanometers ANSI/AAMI SP10-1992. AAMI: Arlington, VA, 1993.

  18. Bland JM, Altman DG . Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307–310.

    Article  CAS  Google Scholar 

  19. Thulin T, Schersten B, Anderson G . Measurement of blood pressure––a routine test in need of standardization. Postgrad Med J 1975; 51: 390–395.

    Article  CAS  Google Scholar 

  20. Yong PG, Geddes LA . The effect of cuff pressure deflation rate on accuracy in indirect measurement of blood pressure with the auscultatory method. J Clin Monit 1987; 3: 155–159.

    Article  CAS  Google Scholar 

  21. Fozard J, Vercryssen M, Reynolds S, Hancock P, Quilter R . Age differences and changes in reaction time: the Baltimore Longitudinal Study of Aging. J Gerontol 1994; 49: 179–189.

    Article  Google Scholar 

Download references

Acknowledgements

We thank the staff and patients who kindly helped us with this research. This study was approved by the Local Research Ethics Committee of Guy's and St Thomas' Hospital NHS Foundation Trust (Ref. EC99/016). All participants provided written informed consent. Partial data were presented at the British Hypertension Society meeting in Cambridge (UK). Individuals performing the study were employed by King's College London. This study was partly funded by Japan Precision Instruments.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A H Shennan.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tasker, F., De Greeff, A. & Shennan, A. Development and validation of a blinded hybrid device according to the European Hypertension Society protocol: Nissei DM-3000. J Hum Hypertens 24, 609–616 (2010). https://doi.org/10.1038/jhh.2009.113

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jhh.2009.113

Keywords

This article is cited by

Search

Quick links